Syncom Formulations (India) Ltd. Share Price

Overview

Syncom Formulations (India) Ltd. share price is currently ₹21.13, up by ₹1.32 (6.66%) from its previous closing price of ₹19.81. The share price has gained 0.43% over the past month and gained 32.23% over the past year. The stock's 52-week low and high are ₹9.85 and ₹27.12, respectively. Syncom Formulations (India) Ltd. has a market capitalisation of ₹ 1,908.20 Cr. The share price was last updated on 16 Nov 2026, 10:59 AM IST.

Syncom Formulations (India) Ltd.
Syncom Formulations (India) Ltd.
SYNCOMF
 ₹0.00
 ₹1.32
6.66%
Healthcare
 ₹0.00(%)1D

Updated: 16 Nov 2026, 10:59:43 am IST

Market Data

Open Price

 ₹20.00

Prev. Close

 ₹19.81
 ₹20.00

Day Low

 ₹22.56

Day High

 ₹9.85

52 Week Low

 ₹27.12

52 Week High

HealthcarePharmaceuticals & Drugs
CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

20.72

Sector PE

45.96

PB Ratio

4.79

Sector PB

6.03

EPS

1.02

Dividend Yield

0.97

Today's Volume

10.975 M

5 Day Avg. Volume

7.279 M

PEG Ratio

0.38

Market Cap.

₹ 1,908.20 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 10% at ₹0.1/Share
23-Sep-202623-Sep-2026

Mutual Fund Ownership

Mutual Fund Holder
Sep 26
Shares held
Oct 26
Shares held
Motilal Oswal BSE Healthcare ETF12.83 k
12.78 k
(0.38%)
Bandhan BSE Healthcare Index Fund - Regular Plan - Growth6.05 k
6.13 k
(1.26%)

About Syncom Formulations (India) Ltd. 👋

Syncom Formulations (India) Limited is an India-based company that is engaged in the pharmaceutical business. The Company is engaged in the development, manufacturing & sale of pharmaceutical products and services& trading of commodities and renting of properties. The Company manufactures and markets more than 200 pharmaceutical formulation products in various dosage forms, like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections and Dry Vial injections, Dry Syrups, Ointments and Inhalers. The Company's domestic division product categories include Cratus Life Care, Cratus Evolve and Cratus Right Nutrition. Its products include Ciprofloxacin Tablets USP 250 mg, Ciprofloxacin Tablets USP 500 mg, Ciprofloxacin Tablets USP 750 mg, Cefazolin For Injection USP 1 gm, Cefotaxime For Injection USP 1 gm, Ceftriaxone for Injection USP 500 mg, Albendazole Oral Suspension USP 100mg, Cetirizine Oral Solution BP, Clotrimazole Cream USP, Compound Benzoic Acid Ointment BP, and others.

Analyst Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Kundan Motwani

Kundan Motwani

27 May • 5:56 PM · SEBI-Registered Analyst

📈 Top 5 Gainers – Indian Stock Market (May 27, 2025)

Despite a choppy session, these stocks stole the spotlight with strong gains today: 🏗️ Shriram Properties – 🔼 +14.56% | ₹96.91 🛡️ Apollo Micro Systems – 🔼 +12.02% | ₹155.50 🧪 Camlin Fine Sciences – 🔼 +11.40% | ₹242.29 💊 Syncom Formulations – 🔼 +11.49% | ₹22.22 🌾 India Pesticides – 🔼 +10.10% | ₹188.97

See More

News & Events

Frequently Asked Questions

What is the share price of Syncom Formulations (India) Ltd.?

What is the market cap of Syncom Formulations (India) Ltd.?

Should I buy Syncom Formulations (India) Ltd. stock now?

What is the 52 week high and low of Syncom Formulations (India) Ltd.?

Is the Syncom Formulations (India) Ltd. stock good to buy?

Is Syncom Formulations (India) Ltd. a good buy for the long term?

Is Syncom Formulations (India) Ltd. overvalued or undervalued?

What is the PE and PB ratio of Syncom Formulations (India) Ltd.?

Start Now